Management of Treatment-Resistant Depression: Challenges and Strategies
Daphne Voineskos, 1, 2 Zafiris J Daskalakis, 1, 2 Daniel M Blumberger 1, 2 1Centre for Addiction and Mental Health, Toronto, Ontario, Canada; 2Department of Psychiatry, University of Toronto, Toronto, Ontario, CanadaCorrespondence: Daniel M BlumbergerCentre for Addiction and Mental Health, 1001 Qu...
Guardado en:
Autores principales: | Voineskos D, Daskalakis ZJ, Blumberger DM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/912b2c2cb46d40fe9cce81675290e46f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy
por: Zafiris J. Daskalakis, et al.
Publicado: (2021) -
Biomarkers for depression: recent insights, current challenges and future prospects
por: Strawbridge R, et al.
Publicado: (2017) -
Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
por: Szarmach J, et al.
Publicado: (2020) -
A Preliminary Randomized Controlled Trial of Different Treatment Regimens for Melancholic Depression
por: Wang Y, et al.
Publicado: (2021) -
Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression
por: Kumar A, et al.
Publicado: (2019)